Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: A systematic review and meta-analysis

Gastrointestinal Endoscopy

Volumn 79, Issue 6, 2014, Pages

  Singh, Siddharth ^a   Manickam, Palaniappan ^b   Amin, Anita V ^b   Samala, Niharika ^b   Schouten, Leo J ^c   Iyer, Prasad G ^a   Desai, Tusar K ^b  

^a MAYO CLINIC   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; BARRETT ESOPHAGUS WITH LOW GRADE DYSPLASIA; CANCER INCIDENCE; CANCER PATIENT; COHORT ANALYSIS; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; FOLLOW UP; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ADENOCARCINOMA; COMPLICATION; ESOPHAGEAL NEOPLASMS; HEALTH; INCIDENCE; PATHOLOGY;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; GLOBAL HEALTH; HUMANS; INCIDENCE;

EID: 84901191532     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2014.01.009     Document Type: Article

References (71)

1. S.J. Spechler, P. Sharma, and R.F. Souza et al. American Gastroenterological Association technical review on the management of Barrett's esophagus Gastroenterology 140 2011 e18 e52
2. T.K. Desai, K. Krishnan, and N. Samala et al. The incidence of esophageal adenocarcinoma in non-dysplastic Barrett's esophagus: a meta-analysis Gut 61 2012 970 976
3. A. Rastogi, S. Puli, and H.B. El-Serag et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis Gastrointest Endosc 67 2008 394 398
4. T.G. Schnell, S.J. Sontag, and G. Chejfec et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607 1619
5. C.H. Lim, D. Treanor, and M.F. Dixon et al. Low-grade dysplasia in Barrett's esophagus has a high risk of progression Endoscopy 39 2007 581 587
6. S. Wani, S.R. Puli, and N.J. Shaheen et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review Am J Gastroenterol 104 2009 502 513
7. S. Bhat, H.G. Coleman, and F. Yousef et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study J Natl Cancer Inst 103 2011 1049 1057
8. F. Hvid-Jensen, L. Pedersen, and A.M. Drewes et al. Incidence of adenocarcinoma among patients with Barrett's esophagus N Engl J Med 365 2011 1375 1383
9. S. Wani Management of low-grade dysplasia in Barrett's esophagus Curr Opin Gastroenterol 28 2012 370 376
10. K.W. Jung, N.J. Talley, and Y. Romero et al. Epidemiology and natural history of intestinal metaplasia of the gastresophageal junction and Barrett's esophagus: a population-based study Am J Gastroenterol 106 2011 1447 1455
11. L.J. Schouten, J. Steevens, and C.J. Huysentruyt et al. Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus Clin Gastroenterol Hepatol 9 2011 754 761
12. A. Stang Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 25 2010 603 605
13. D. Moher, A. Liberati, and J. Tetzlaff et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
14. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trial 7 1986 177 188
15. A.J. Sutton Methods for meta-analysis in medical research 2000 J. Wiley Chichester (New York)
16. F. Kanwal, and D. White Systematic reviews and meta-analyses in clinical gastroenterology and hepatology Clin Gastroenterol Hepatol 10 2012 1184 1186
17. J.P. Higgins, S.G. Thompson, and J.J. Deeks et al. Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
18. S.G. Thompson, and S.J. Pocock Can meta-analyses be trusted? Lancet 338 1991 1127 1130
19. G.H. Guyatt, A.D. Oxman, and R. Kunz et al. GRADE guidelines: 7. Rating the quality of evidence - inconsistency J Clin Epidemiol 64 2011 1294 1302
20. P.J. Easterbrook, J.A. Berlin, and R. Gopalan et al. Publication bias in clinical research Lancet 337 1991 867 872
21. N.J. Shaheen, P. Sharma, and B.F. Overholt et al. Radiofrequency ablation in Barrett's esophagus with dysplasia N Engl J Med 360 2009 2277 2288
22. O. Pech, M. Vieth, and D. Schmitz et al. Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett's esophagus Scand H Gastroenterol 42 2007 682 688
23. S. Oberg, J. Wenner, and J. Johansson et al. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma Ann Surg 242 2005 49 54
24. J. Martinek, M. Benes, and P. Brandtl et al. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study Endoscopy 40 2008 711 716
25. L. Murray, P. Watson, and B. Johnston et al. Risk of adenocarcinoma in Barrett's esophagus: population based study BMJ 327 2003 534 535
26. A.P. Weston, S.K. Banerjee, and P. Sharma et al. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression Am J Gastroenterol 96 2001 1355 1362
27. M. Skacel, R.E. Petras, and L.A. Rybicki et al. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression Am J Gastroenterol 97 2002 2508 2513
28. A. Srivastava, J.L. Hornick, and X. Li et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus Am J Gastroenterol 102 2007 483 493
29. P. Sharma, G.W. Falk, and A.P. Weston et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus Clin Gastroenterol Hepatol 4 2006 566 572
30. J.F. Bartlesman, W. Hameeteman, and G.N. Tytgat Barrett's esophagus Eur J Cancer Prev 1 1992 323 325
31. D.J. Drewitz, R.E. Sampliner, and H.S. Garewal The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years Am J Gastroenterol 92 1997 212 215
32. A. Csendes, I. Braghetto, and P. Burdiles et al. Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation Surgery 123 1998 645 657
33. R. Ferraris, L. Bonelli, and M. Conio et al. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE) Eur J Gastroenterol Hepatol 9 1997 881 885
34. J.B. O'Connor, G.W. Falk, and J.E. Richter The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry Am J Gastroenterol 94 1999 2037 2042
35. B.K. Oelschlager, M. Barreca, and L. Chang et al. Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery Ann Surg 238 2003 458 464 discussion 64-6
36. A.E. Abbas, C. Deschamps, and S.D. Cassivi et al. Barrett's esophagus: the role of laparoscopic fundoplication Ann Thorac Surg 77 2004 393 396
37. S.J. Murphy, W. Dickey, and D. Hughes et al. Surveillance for Barrett's esophagus: results from a programme in Northern Ireland Eur J Gastoenterol Hepatol 17 2005 1029 1035
38. K.K. Basu, B. Pick, and J.S. de Caestecker Audit of a Barrett's epithelium surveillance database Eur J Gastoenterol Hepatol 16 2004 171 175
39. T.R. DeMeester, S.E. Attwood, and T.C. Smyrk et al. Surgical therapy in Barrett's esophagus Ann Surg 212 1990 528 540
40. J.M. O'Riordan, P.J. Byrne, and N. Ravi et al. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery Am J Surg 188 2004 27 33
41. P. Parrilla, L.F. Martinez de Haro, and A. Ortiz et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus Ann Surg 237 2003 291 298
42. L.Q. Chen, C.Y. Hu, and L. Gaboury et al. Proliferative activity in Barrett's esophagus before and after antireflux surgery Ann Surg 234 2001 172 180
43. S.P. Bowers, S.G. Mattar, and C.D. Smith et al. Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus J Gastrointest Surg 6 2002 532 538
44. D.E. Low, D.S. Levine, and D.H. Dail et al. Histological and anatomic changes in Barrett's esophagus after antireflux surgery Am J Gastroenterol 94 1999 80 85
45. L. Biertho, B. Dallemagne, and J.M. Dewandre et al. Laparoscopic treatment of Barrett's esophagus: long-term results Surg Endosc 21 2007 11 15
46. K.M. Desai, N.J. Soper, and M.M. Frisella et al. Efficacy of laparoscopic antireflux surgery in patients with Barrett's esophagus Am J Surg 186 2003 652 659
47. G. Zaninotto, M. Cassaro, and G. Pennelli et al. Barrett's epithelium after antireflux surgery J Gastrointest Surg 9 2005 1253 1260
48. S. Wani, G.W. Falk, and J. Post et al. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus Gastroenterology 141 2011 1179 1186
49. P. Gatenby, J. Ramus, and C. Caygill et al. Routinely diagnosed low-grade dysplasia in Barrett's esophagus: a population-based study of natural history Histopathology 54 2009 814 819
50. G.S. Dulai, P.G. Shekelle, and D.M. Jensen et al. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort Am J Gastroenterol 100 2005 775 783
51. M. Vieth, B. Schubert, and K. Lang-Schwarz et al. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study Endoscopy 38 2006 1201 1205
52. W.L. Curvers, F.J. ten Kate, and K.K. Krishnadath et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated Am J Gastroenterol 105 2010 1523 1530
53. M. Conio, S. Blanchi, and G. Lapertosa et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study Am J Gastroenterol 98 2003 1931 1939
54. B.J. Reid, D.S. Levine, and G. Longton et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 2000 1669 1676
55. J. Alcedo, A. Ferrandez, and J. Arenas et al. Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance Dis Esophagus 22 2009 239 248
56. V. Switzer-Taylor, M. Schlup, and R. Lubcke et al. Barrett's esophagus: a retrospective analysis of 13 years surveillance J Gastoenterol Hepatol 23 2008 1362 1367
57. M. Younes, A. Ertan, and L.V. Lechago et al. p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia Dig Dis Sci 42 1997 697 701
58. T. Wong, J. Tian, and A.B. Nagar Barrett's surveillance identifies patients with early esophageal adenocarcinoma Am J Med 123 2010 462 467
59. M. Miros, P. Kerlin, and N. Walker Only patients with dysplasia progress to adenocarcinoma in Barrett's esophagus Gut 32 1991 1441 1446
60. E. Montgomery, J.R. Goldblum, and J.K. Greenson et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study Human Path 32 2001 379 388
61. M. Hage, P.D. Siersema, and H. van Dekken et al. Esophageal cancer incidence and mortality in patients with long-segment Barrett's esophagus after a mean follow-up of 12.7 years Scand J Gastroenterol 39 2004 1175 1179
62. W. Hameeteman, G.N. Tytgat, and H.J. Houthoff et al. Barrett's esophagus: development of dysplasia and adenocarcinoma Gastroenterology 96 1989 1249 1256
63. S.J. Spechler, A.H. Robbins, and H.B. Rubins et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 87 1984 927 933
64. S.P. Wilkinson, L. Biddlestone, and S. Gore et al. Regression of columnar-lined (Barrett's) esophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy Aliment Pharmacol Ther 13 1999 1205 1209
65. A. Ajumobi, K. Bahjri, and C. Jackson et al. Surveillance in Barrett's esophagus: an audit of practice Dig Dis Sci 55 2010 1615 1621
66. S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
67. L.M. Liao, T.L. Vaughan, and D.A. Corley et al. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis Gastroenterology 142 2012 442 452
68. S. Singh, A.G. Singh, and P.P. Singh et al. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 2013 620 629
69. F. Kastelein, M.C. Spaander, and E.W. Steyerberg et al. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus Clin Gastroenterol Hepatol 11 2013 382 388
70. C. Hur, S.E. Choi, and J.H. Rubenstein et al. The cost effectiveness of radiofrequency ablation for Barrett's esophagus Gastroenterology 143 2012 567 575
71. D.A. Corley, K. Mehtani, and C. Quesenberry et al. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas Gastroenterology 145 2013 312 319